, a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of hepatitis B and other viral infections, today announced that Radhakrishnan P. (Kris) Iyer, Ph.D.,
Chief Scientific
Officer of Spring Bank, will present at the American Association for the Study of Liver Disease (AASLD) and Industry Colloquium: Novel Targets and Therapies in Liver Disease, being held on March 20-21, 2015, at the Hilton Durham in Durham/Research Triangle Park, North Carolina.